Efavirenz + Emtricitabine + Tenofovir + Tenofovir Disoproxil

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Efavirenz efavirenz
Emtricitabine emtricitabine
Tenofovir tenofovir
Tenofovir Disoproxil tenofovir-disoproxil

Brands with this exact combination

Brand	Composition & strength	Manufacturer
Efavirenz/Emtricitabine/Tenofovir disoproxil MylanCZ EU LV	tablet ×7 Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir Disoproxil tablet ×3 Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir 245 mg unknown Efavirenz + Emtricitabine + Tenofovir Disoproxil	Mylan Pharmaceuticals Limited, Dublin
Efavirenz/Emtricitabine/Tenofovir disoproxil KrkaCZ EU LV	tablet ×2 Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir Disoproxil tablet ×2 Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir 245 mg unknown Efavirenz + Emtricitabine + Tenofovir Disoproxil	KRKA, d.d., Novo mesto, Slovenia
Efavirenz/Emtricitabine/Tenofovir disoproxil ZentivaEU LV	tablet ×2 Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir 245 mg unknown Efavirenz + Emtricitabine + Tenofovir Disoproxil	Zentiva, k.s., Czech Republic

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.